• Phoenix Rising needs funds to operate: please consider donating to support PR

Clinical Trial for Symptomatic Neurogenic Orthostatic Hypotension


Senior Member
Northern California
Hi, Phoenix Risers!

I was on the UT Southwest Medical Center (Dallas, TX) website today, and I came across a clinical trial that I thought may be of interest to some of you.

I'll try to post a link here, but you will have to go to the Clinical Trials website to see full details, contact info, and eligibility requirements.

Clinical Effect of Ampreloxetine (TD-9855) for Treating snOH in Subjects With Primary Autonomic Failure
Description:A Phase 3 study to evaluate efficacy, safety, and tolerability of ampreloxetine (TD-9855) in subjects with primary autonomic failures (MSA, PD, or PAF) and snOH with up to 4 weeks of treatment.
Contact(s):Call 214-648-5005

Principal Investigator: Meredith Bryarly
Principal Investigator ID: 126795
Gender: All
Age: 30 Years and over
Phase: Phase 3
Healthy Volunteers:
This study is NOT accepting healthy volunteers

System ID: NCT03750552
IRB Number: STU-2018-0337